Unlocking the Power of Tango Therapeutics: Exciting Inducement Grants Under NASDAQ Listing Rule Revealed!
Tango Therapeutics Announces Inducement Grants The Latest News from Tango Therapeutics BOSTON, March 06, 2023 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that, effective March 1, 2023, the Compensation Committee of Tango Therapeutics’ Board of Directors…